4/A: GeneDx Amends Ownership Data, Corrects Past Errors

GeneDx Holdings Corp. Director Eli Casdin filed an amended Form 4 to correct clerical errors in previous beneficial ownership reports.

Summary

• Eli Casdin, a Director and 10% Owner of GeneDx Holdings Corp. (WGS), filed an amended Form 4 (Form 4/A) to correct inaccuracies in prior beneficial ownership statements.
• The amendment addresses clerical errors that led to an overstatement of Mr. Casdin's direct Class A Common Share holdings by 1,376 shares in filings from March 6, 2024, through June 5, 2024.
• It also corrects an understatement of 4,452 shares in the Form 4 filed on August 5, 2024, which failed to reflect 7,594 shares held directly after 5,828 Restricted Stock Units (RSUs) vested on June 20, 2024.
• The filing reports a transaction on June 18, 2025, involving the acquisition of 12,924 Class A Common Shares from the conversion of RSUs at a price of $0.
• Following the reported transactions, Mr. Casdin directly beneficially owns 20,518 Class A Common Shares.
• Indirect beneficial ownership includes 3,507,164 shares through Casdin Partners Master Fund, L.P., 19,247 shares through Casdin Partners GP, LLC, and 333,144 shares through CMLS Holdings LLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the need for an amendment due to clerical errors is a minor negative, the proactive correction of these errors is a positive for transparency and accuracy, balancing the overall sentiment.

Positives

• The company and reporting person are proactively correcting past clerical errors, enhancing data accuracy and transparency for investors.

Negatives

• Prior Form 4 filings contained clerical errors, leading to inaccurate reporting of beneficial ownership for a period.

Risks

• The occurrence of clerical errors in SEC filings, even if corrected, highlights a minor risk in data accuracy and internal controls for reporting.

Future Outlook

Restricted Stock Units (RSUs) are set to vest on the earlier of the next annual meeting of the Issuer's shareholders following the grant date or the first anniversary of the grant date, contingent on the Reporting Person's continued service to the Issuer.

Management Comments

• Eli Casdin disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his pecuniary interest, if any, therein.

Industry Context

This filing is a routine amendment to an insider ownership report and does not provide broader insights into industry trends or competitive landscape within the biotechnology or genomics sector.

Related Party Transactions

• Eli Casdin's indirect beneficial ownership through Casdin Partners Master Fund, L.P., Casdin Partners GP, LLC, and CMLS Holdings LLC represents standard related party structures for investment entities where he holds managing roles.

Stakeholder Impact

• Shareholders: Improved accuracy of insider ownership data, providing a clearer picture of a significant shareholder's holdings.
• Regulatory Authorities: Ensures compliance with Section 16(a) reporting requirements by correcting previously filed information.

Next Steps

• Vesting of Restricted Stock Units (RSUs) on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date.

Key Dates

Keywords

GeneDx Holdings Corp., WGS, SEC Form 4/A, Beneficial Ownership, Eli Casdin, Director, 10% Owner, Restricted Stock Units, RSU, Clerical Error, Amendment